Elvira Munteis

1.3k total citations
37 papers, 766 citations indexed

About

Elvira Munteis is a scholar working on Pathology and Forensic Medicine, Immunology and Epidemiology. According to data from OpenAlex, Elvira Munteis has authored 37 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 10 papers in Immunology and 8 papers in Epidemiology. Recurrent topics in Elvira Munteis's work include Multiple Sclerosis Research Studies (18 papers), Immune Cell Function and Interaction (9 papers) and Acute Ischemic Stroke Management (6 papers). Elvira Munteis is often cited by papers focused on Multiple Sclerosis Research Studies (18 papers), Immune Cell Function and Interaction (9 papers) and Acute Ischemic Stroke Management (6 papers). Elvira Munteis collaborates with scholars based in Spain, Sweden and Netherlands. Elvira Munteis's co-authors include Jaume Roquer, José Rodríguez, Ángel Ois, Ana Rodríguez-Campello, Meritxell Gomis, Miguel López‐Botet, Jordi Jiménez-Conde, Elisa Cuadrado‐Godia, Víctor Puente and Xavier Montalbán and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Elvira Munteis

37 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elvira Munteis Spain 19 275 230 204 177 131 37 766
Wojciech Ambrosius Poland 13 155 0.6× 157 0.7× 89 0.4× 56 0.3× 59 0.5× 28 541
Steven Dinsmore United States 7 497 1.8× 240 1.0× 126 0.6× 219 1.2× 54 0.4× 10 957
Eva Astrid Jacobsen Norway 12 139 0.5× 221 1.0× 74 0.4× 76 0.4× 54 0.4× 27 539
Nancy Futrell United States 9 292 1.1× 232 1.0× 69 0.3× 105 0.6× 67 0.5× 24 854
A Thiry Belgium 10 443 1.6× 93 0.4× 99 0.5× 61 0.3× 72 0.5× 22 765
Angeliki Filippatou United States 18 208 0.8× 289 1.3× 371 1.8× 28 0.2× 165 1.3× 38 802
Eisuke Ozawa Japan 16 166 0.6× 422 1.8× 40 0.2× 66 0.4× 100 0.8× 62 1.1k
Pil‐Woo Huh South Korea 22 209 0.8× 602 2.6× 150 0.7× 59 0.3× 40 0.3× 46 1.1k
Olaf Hoffmann Germany 15 119 0.4× 173 0.8× 112 0.5× 30 0.2× 25 0.2× 45 518
Yasuhiro Suzuki Japan 15 119 0.4× 243 1.1× 136 0.7× 60 0.3× 17 0.1× 63 877

Countries citing papers authored by Elvira Munteis

Since Specialization
Citations

This map shows the geographic impact of Elvira Munteis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elvira Munteis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elvira Munteis more than expected).

Fields of papers citing papers by Elvira Munteis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elvira Munteis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elvira Munteis. The network helps show where Elvira Munteis may publish in the future.

Co-authorship network of co-authors of Elvira Munteis

This figure shows the co-authorship network connecting the top 25 collaborators of Elvira Munteis. A scholar is included among the top collaborators of Elvira Munteis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elvira Munteis. Elvira Munteis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez, José, et al.. (2025). Ongoing phase 2 agents for multiple sclerosis: could we break the phase 3 trial deadlock?. Expert Opinion on Investigational Drugs. 34(3). 217–229. 1 indexed citations
2.
Zabalza, Ana, Andrea Vera, Elisenda Alari‐Pahissa, et al.. (2020). Impact of cytomegalovirus infection on B cell differentiation and cytokine production in multiple sclerosis. Journal of Neuroinflammation. 17(1). 161–161. 19 indexed citations
3.
Moreira, Antía, Elisenda Alari‐Pahissa, Elvira Munteis, et al.. (2019). Adaptive Features of Natural Killer Cells in Multiple Sclerosis. Frontiers in Immunology. 10. 2403–2403. 16 indexed citations
4.
Quirant‐Sánchez, Bibiana, José Vicente Hervás, Aina Teniente‐Serra, et al.. (2018). Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients. CNS Neuroscience & Therapeutics. 24(12). 1175–1184. 24 indexed citations
5.
Royo, Inmaculada, et al.. (2016). Male anorgasmia as initial symptom of transverse myelitis. Neurología (English Edition). 31(6). 414–416. 1 indexed citations
6.
Ortíz, Miguel A, José C. Álvarez‐Cermeño, José Rodríguez, et al.. (2015). Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis. PLoS ONE. 10(8). e0134414–e0134414. 4 indexed citations
7.
Escartín, Antonio, Francisco Coret, Bonaventura Casanova, et al.. (2013). Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers. BMC Neurology. 13(1). 82–82. 3 indexed citations
8.
Muiño, Elena, Susana González-Suárez, Santiago Medrano, et al.. (2013). Progressive multifocal leukoencephalopathy in an immunocompetent patient. Journal of the Neurological Sciences. 333. e408–e409. 1 indexed citations
9.
Rodríguez, José, Miguel López‐Botet, Elvira Munteis, et al.. (2011). Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis. Clinical Immunology. 141(3). 348–356. 55 indexed citations
10.
Rodríguez, José, Andrea Sáez‐Borderías, Elvira Munteis, et al.. (2010). Natural killer receptors distribution in multiple sclerosis: Relation to clinical course and interferon-beta therapy. Clinical Immunology. 137(1). 41–50. 22 indexed citations
11.
Sánchez, Antonio, José Rodríguez, Elisa Cisneros, et al.. (2009). Multiple sclerosis associates with LILRA3 deletion in Spanish patients. Genes and Immunity. 10(6). 579–585. 37 indexed citations
12.
Cuadrado‐Godia, Elisa, et al.. (2009). Perfil lipídico durante el primer año de tratamiento con interferón beta en pacientes con esclerosis múltiple. Medicina Clínica. 132(7). 259–261. 1 indexed citations
13.
Rodríguez, José, Elvira Munteis, Mar Carreño, et al.. (2008). Cannabis use in Spanish patients with multiple sclerosis: Fulfilment of patients' expectations?. Journal of the Neurological Sciences. 273(1-2). 103–107. 18 indexed citations
14.
Ois, Ángel, José Rodríguez, Elvira Munteis, et al.. (2008). Steno-Occlusive Arterial Disease and Early Neurological Deterioration in Acute Ischemic Stroke. Cerebrovascular Diseases. 25(1-2). 151–156. 60 indexed citations
15.
Roquer, Jaume, Ángel Ois, Ana Rodríguez-Campello, et al.. (2007). Atherosclerotic Burden and Early Mortality in Acute Ischemic Stroke. Archives of Neurology. 64(5). 699–699. 28 indexed citations
16.
Roquer, Jaume, Ana Rodríguez-Campello, Meritxell Gomis, et al.. (2006). Comparison of the impact of atrial fibrillation on the risk of early death after stroke in women versus men. Journal of Neurology. 253(11). 1484–1489. 31 indexed citations
17.
Rodríguez, José, Elvira Munteis, & Jaume Roquer. (2006). Periodic hyperthermia and abnormal circadian temperature rhythm in a patient with multiple sclerosis. Multiple Sclerosis Journal. 12(4). 515–517. 13 indexed citations
18.
Munteis, Elvira, et al.. (2006). Anorectal dysfunction in multiple sclerosis. Multiple Sclerosis Journal. 12(2). 215–218. 30 indexed citations
19.
Roquer, Jaume, Ana Rodríguez-Campello, Meritxell Gomis, et al.. (2005). Previous antiplatelet therapy is an independent predictor of 30?day mortality after spontaneous supratentorial intracerebral hemorrhage. Journal of Neurology. 252(4). 412–416. 87 indexed citations
20.
Blanco, Yolanda, Manuel Gómez‐Choco, Juan I. Aróstegui, et al.. (2005). No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis. Neuroscience Letters. 396(3). 217–219. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wojciech Ambrosius Breakdown of academic impact, for papers by Steven Dinsmore Breakdown of academic impact, for papers by Eva Astrid Jacobsen Breakdown of academic impact, for papers by Nancy Futrell Breakdown of academic impact, for papers by A Thiry Breakdown of academic impact, for papers by Angeliki Filippatou Breakdown of academic impact, for papers by Eisuke Ozawa Breakdown of academic impact, for papers by Pil‐Woo Huh Breakdown of academic impact, for papers by Olaf Hoffmann Breakdown of academic impact, for papers by Yasuhiro Suzuki
Rankless by CCL
2026